HUMANITY is a pharmaceutical concern specializing in the development and production of medications. HUMANITY’s current product portfolio lists more than 700 discrete medications covering a range of dosages and delivery systems. HUMANITY currently also has 156 new products in varying stages of development (Humanity Research and Development Center). Our products are represented in all 13 ATC codes, meaning that our medications are at work in every branch of modern medicine. Our Research and Development Center team specializes in the formulation of new delivery systems of active pharmaceutical agents, meaning that our primary focus is placed on improving medication effectiveness and reducing side effects. In addition, our R&D Innovation Department is dedicated to the creation of comparable pharmaceutical formulations, or “generic drugs”. While addressing the needs of patients requiring treatment of every sort, HUMANITY places a concentrated emphasis on the development of products for the treatment of illnesses which weigh especially heavily on modern society. We do extensive research into the treatment of cancer, nervous system disorders – Multiple Sclerosis and Alzheimer’s Disease, in particular – cardiovascular disease, Type II diabetes, and a range of pain syndromes. Above all, HUMANITY is dedicated to the production of medications that meet and exceed global standards of excellence, consistency, and reliability. To us, the alternative is simply unacceptable. People – their lives, their welfare – depend on the work we do. We pour ourselves into the products we make.